Comparison Chart Jasper Therapeutics, Inc.

Stocks

JSPR

US4718712023

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
0.7086 ^USD	+3.23%		+1.27%	-61.28%

08-14	Jasper Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-12	Piper Sandler Initiates Jasper Therapeutics With Overweight Rating, $2 Price Target	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	JASPER THERAPEUTICS, INC.	Bio Therapeutic Drugs	+3.23%	+1.27%	-61.28%	-73.95%	-99.29%	23.58M